Cytek Biosciences Inc (CTKB)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.75B
EV to revenue ratio (TTM)
2.53
EV to ebitda
222.69
Financial Performance
Revenue (TTM)
$0.21B
Gross profit (TTM)
$0.11B
EBITDA
-$0.04B
Profitability
Operating margin (TTM)
-22.50%
Profit margin
-39.10%
Return on assets (TTM)
-6.20%
Return on equity (TTM)
-23.20%
Per Share Metrics
Revenue per share (TTM)
$1.61
EPS
-$0.63
Diluted EPS (TTM)
-$0.63
Book value
$2.46
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
370.37
PEG ratio
n/a
Price to sales ratio (TTM)
3.63
Price to book ratio (TTM)
2.35
Growth
Quarterly earnings growth (YoY)
1.80%
Quarterly revenue growth (YoY)
73.50%
Analyst Sentiment
Strong buy
1
Buy
1
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.14